These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 22190262

  • 21. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J, Andrès E, Noel E, Koumarianou A, Blicklé JF, Maloisel F.
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [Abstract] [Full Text] [Related]

  • 22. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
    Johansson E, Engervall P, Landgren O, Grimfors G, Widell S, Rezai S, Björkholm M.
    Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
    [Abstract] [Full Text] [Related]

  • 23. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.
    Clin Ther; 2014 Mar 01; 36(3):385-8. PubMed ID: 24594069
    [Abstract] [Full Text] [Related]

  • 24. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.
    Clausen MR, Segel E, Brandsborg M, d'Amore F.
    Eur J Haematol; 2011 Mar 01; 86(3):256-9. PubMed ID: 21166717
    [Abstract] [Full Text] [Related]

  • 25. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
    Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar-Jahromi M, Esfahani FS.
    Am J Hematol; 2008 May 01; 83(5):376-81. PubMed ID: 18183613
    [Abstract] [Full Text] [Related]

  • 26. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR, Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP.
    Ann Hematol; 2006 Jun 01; 85(6):400-6. PubMed ID: 16550390
    [Abstract] [Full Text] [Related]

  • 27. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A, Konopka L, Maślanka K.
    Int J Lab Hematol; 2008 Feb 01; 30(1):58-64. PubMed ID: 18190469
    [Abstract] [Full Text] [Related]

  • 28. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center.
    Ismet A, Irfan K, Emin K, AlI EM, Ramazan U, Mustafa B, Onur O.
    Clin Lab Haematol; 2004 Jun 01; 26(3):211-4. PubMed ID: 15163320
    [Abstract] [Full Text] [Related]

  • 29. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y, Wang XM, Mao M, Zhang XY, Fu L, Ai HM, Zhang LX.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar 01; 33(3):204-6. PubMed ID: 22781608
    [Abstract] [Full Text] [Related]

  • 30. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
    Li HQ, Zhang L, Zhao H, Ji LX, Yang RC.
    Chin Med J (Engl); 2005 Jan 05; 118(1):34-7. PubMed ID: 15642223
    [Abstract] [Full Text] [Related]

  • 31. Age old dapsone in the treatment of idiopathic thrombocytopenic purpura--a case report with review.
    Kundu R, Sethi N, Ghose A, Chaudhary R.
    Am J Ther; 2013 Jan 05; 20(6):e723-5. PubMed ID: 21822117
    [Abstract] [Full Text] [Related]

  • 32. [Treatment outcome of immune thrombocytopenia].
    Iványi JL, Marton E, Plander M.
    Orv Hetil; 2012 Oct 14; 153(41):1613-21. PubMed ID: 23045311
    [Abstract] [Full Text] [Related]

  • 33. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J.
    Br J Haematol; 2014 Oct 14; 167(2):243-51. PubMed ID: 25041261
    [Abstract] [Full Text] [Related]

  • 34. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.
    Br J Haematol; 2004 Apr 14; 125(2):232-9. PubMed ID: 15059147
    [Abstract] [Full Text] [Related]

  • 35. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb 14; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 36. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP).
    Alasfoor K, Alrasheed M, Alsayegh F, Mousa SA.
    Ann Hematol; 2009 Mar 14; 88(3):239-43. PubMed ID: 18704420
    [Abstract] [Full Text] [Related]

  • 37. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
    Palandri F, Polverelli N, Catani L, Sollazzo D, Romano M, Levorato M, Vianelli N.
    Am J Hematol; 2014 Nov 14; 89(11):1047-50. PubMed ID: 25103500
    [Abstract] [Full Text] [Related]

  • 38. Dapsone for immune thrombocytopenic purpura in children and adults.
    Patel AP, Patil AS.
    Platelets; 2015 Nov 14; 26(2):164-7. PubMed ID: 24512442
    [Abstract] [Full Text] [Related]

  • 39. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
    Srinivasan S, Sabapathy K, Bharadwaj TP, Sethuraman S.
    J Assoc Physicians India; 2003 Feb 14; 51():159-62. PubMed ID: 12725258
    [Abstract] [Full Text] [Related]

  • 40. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M, Suvajdzic N, Colović N, Tomin D, Vidović A, Palibrk V.
    Platelets; 2011 Feb 14; 22(2):153-6. PubMed ID: 21142405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.